!!Merab Kokaia - Curriculum Vitae
\\
__EDUCATION__
\\
*1998 Docent Degree, Experimental Neurology, Lund University, Sweden\\
*1991 Habilitation Degree (Doctor of Biological Sciences), Neuroscience, Institute of Physiology, Georgian Academy of Sciences, USSR\\
*1983 PhD Degree (Candidate of Biological Sciences) Neurophysiology, Institute of Physiology, Georgian Academy of Sciences, USSR\\
*1978 BA in Biology, Tbilisi State University, Georgia, USSR
\\
__CURRENT POSITIONS__
\\
*2008 -  Professor at the Division of Neurology, Dept. Clinical Sciences, Lund University, Sweden \\
*2011 -  Professor at Chavchavadze State University, Tbilisi, Georgia\\
*2013 -  Director of Epilepsy Center, Dept. Clinical Sciences, Lund University, Sweden\\
*2013 - 2018 Coordinator of EC FP7 Large Collaborative Project EPITARGET \\
\\
__PREVIOUS POSITIONS__
\\ 
*2002 - 2008 Associate Professor (Lektor), Division of Neurology, Dept. Clinical Sciences, Lund University, Sweden\\
*1996 – 2002 Assistant Professor (Forskarassistent), Division of Neurology, Dept. Clinical Sciences, Lund University, Sweden\\
*1996 Postdoc, Prof. Dimitri Kullmann's laboratory, Dept. Neurology, University College London, UK \\
*1991 – 1996 Postdoc, Division of Neurology, Dept. Clinical Sciences, Lund University, Sweden\\
\\
__SUPERVISION OF GRADUATE STUDENTS AND POSTDOCTORAL FELLOWS__
\\ \\
16 PhD students, 12 Postdocs, and more than 26 graduate students \\
\\
__TEACHING ACTIVITIES__
\\
*Ongoing: Medical School at LU, T2 Course NoR, tutor since more than 10 y\\
*Ongoing: Course Director and lecturer for Biomedicine Masters program, Course BIM22, since more than 10 y\\
*2017 International Epilepsy Summer School, VENICE INTERNATIONAL UNIVERSITY, since more than 10y, (every third year).\\
*2015 Latin American Summer School on Epilepsy (LASSE) Sao Paulo, Brazil \\
*2009 Neuroscience School in Trieste, Italy\\
*2008 – Baltic summer Schools, different locations, multiple times\\
*Neuroscience School at the Karolinska institute, Stockholm, Sweden (multiple times)
\\
__ORGANISATION OF SCIENTIFIC MEETINGS__
\\
*2014 European Congress on Epileptology, Stockholm, Sweden - member of scientific organising committee, Responsible for the Basic Research part.\\
*2014 Segerfalk symposium, Lund, Sweden - member of scientific organising committee\\
*2012 Svenska Epilepsisällskapets (SES) Workshop - Chair of scientific organising committee\\
*Multiple symposia and sessions at various international neuroscience and epilepsy meetings and congresses\\
*Multiple symposia and workshops in relation to EU Funded Consortia Annual meetings
\\
__INSTITUTIONAL RESPONSIBILITIES__
\\
*2013 – Director of Epilepsy Center, Lund University, Sweden\\
\\
__COMMISSIONS OF TRUST__
\\
*Board member of Svenska Epilepsisällskapet, Sweden\\
*Neurobiology Commission of International League Against Epilepsy (ILAE)\\
*Dissemination Taskforce Co-Chair, International League Against Epilepsy (ILAE)
\\
__MEMBERSHIPS OF SCIENTIFIC SOCIETIES__
\\
*Elected Member of Royal Physiographic Society in Lund
\\
__MAJOR COLLABORATIONS__
\\
*Co-ordinator of EC FP7 Large Collaborative Project EPITARGET (18 groups in Europe and Israel), Stanford University, Prof. Karl Deisseroth, since 2006 - Optogenetics
\\
__INTERNATIONAL EDITORIAL ASSIGNMENTS:__
\\
*Epilepsy Research (Associate Editor)\\
*Epilepsia (Editorial Board Member)\\
*Epilepsy Research and Treatment (Editorial Board Member)\\
*Frontiers in Neuroscience (Invited Editor)
\\
__CURRENT GRANTS:__
\\ \\
Vetenskapsrådet , EC FP7 EPITARGET (2013-2018, 12 mil €, Coordinator), EC Marie Curie grant Train4CRS, 2016-2020), SOEB (2017-2020, 1.5 mil kr), Hjärnfonden (2017-2018) and multiple other grants.
\\ \\
__EXPERT REVIEWER__
\\
*Nature Biotechnology\\
*Nature Neuroscience\\
*The Journal of Neuroscience\\
*Brain, and many others
\\
__PUBLICATIONS__
\\ \\
More than 125, including book chapters and reviews
\\ \\
__PATENTS__
\\
*Use of nucleic acid sequences for the treatment of neurological and phychiatric diseases, vectors and compositions. EU Patent number: EP2046394 (2014)\\
*Use of nucleic acid sequences for the treatment of epilepsy. US patent number: 8,901,094 (2014) \\
*Treatment of cerebral ischemia and cerebral damage with neuroprotective agents. US patent number: 5,972,924 (1999)\\ \\